SCHEMBL2274013

SCHEMBL2274013

O=C(/C=C/c1ccc(Cl)c(Cl)c1)Nc1cc(Oc2ccccc2)ccc1C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 6/20 0.53
MEN1 O00255 4/20 0.53
KMT2A Q03164 4/20 0.53
MAPT P10636 4/20 0.53
NPC1 O15118 2/20 0.53
RAB9A P51151 2/20 0.53
SMN1; SMN2 Q16637 2/20 0.53
TP53 P04637 3/20 0.50
ALDH1A1 P00352 3/20 0.50
HPGD P15428 3/20 0.50
CYP3A4 P08684 2/20 0.50
HIF1A Q16665 2/20 0.50
TRPM8 Q7Z2W7 2/20 0.50
CYP1A2 P05177 1/20 0.50
CYP2C9 P11712 1/20 0.50
CYP2C19 P33261 1/20 0.50
HSD17B10 Q99714 1/20 0.50
KDM4E B2RXH2 1/20 0.50
ABCC4 O15439 1/20 0.50
HPGDS O60760 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2274015 1.00 TRPA1 (0.53) TRPA1MEN1KMT2AMAPTNPC1
SCHEMBL2278165 0.89 TRPA1 (0.68) TRPA1MEN1KMT2AMAPTNPC1
SCHEMBL2278170 0.89 TRPA1 (0.68) TRPA1MEN1KMT2AMAPTNPC1
SCHEMBL2270181 0.87 TRPA1 (0.60) TRPA1MEN1KMT2AMAPTNPC1
SCHEMBL2270176 0.87 TRPA1 (0.60) TRPA1MEN1KMT2AMAPTNPC1
SCHEMBL2277888 0.87 MEN1 (0.57) TRPA1MEN1KMT2AMAPTNPC1
SCHEMBL2277892 0.87 MEN1 (0.57) TRPA1MEN1KMT2AMAPTNPC1
SCHEMBL2278127 0.85 TRPA1 (0.62) TRPA1MEN1KMT2AMAPTNPC1
SCHEMBL2278133 0.85 TRPA1 (0.62) TRPA1MEN1KMT2AMAPTNPC1
SCHEMBL6520762 0.84 TRPA1 (0.74) TRPA1MEN1KMT2AMAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7999132-B2 Anthranilic acid derivative or salt thereof TOYAMA CHEMICAL CO., LTD. (JP) 2011-08-16 US disclosed
US-20090240052-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2009-09-24 US disclosed
EP-1820795-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2007-08-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090240052-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF MMP13, MMP26, MMP11 TRPA1 2714/4885MEN1 3105/4885KMT2A 1669/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.